Loader

Pathways

PathWhiz ID Pathway Meta Data

PW392571

Pw392571 View Pathway
metabolic

Taurine Metabolism

Escherichia coli W
Taurine enters into the cytoplasm through a taurine ATP-binding cassette (ABC) transporters. Once inside, the enzyme taurine dioxygenase encourages the interaction between taurine, oxoglutaric acid and oxygen resulting in the release of succinic acid, sulfite, aminoacetaldehyde, and carbon dioxide.

PW393721

Pw393721 View Pathway
metabolic

Taurine Metabolism

Acinetobacter haemolyticus NIPH 261
Taurine enters into the cytoplasm through a taurine ATP-binding cassette (ABC) transporters. Once inside, the enzyme taurine dioxygenase encourages the interaction between taurine, oxoglutaric acid and oxygen resulting in the release of succinic acid, sulfite, aminoacetaldehyde, and carbon dioxide.

PW393771

Pw393771 View Pathway
metabolic

Taurine Metabolism

Pseudomonas monteilii NBRC 103158 = DSM 14164
Taurine enters into the cytoplasm through a taurine ATP-binding cassette (ABC) transporters. Once inside, the enzyme taurine dioxygenase encourages the interaction between taurine, oxoglutaric acid and oxygen resulting in the release of succinic acid, sulfite, aminoacetaldehyde, and carbon dioxide.

PW000774

Pw000774 View Pathway
metabolic

Taurine Metabolism

Escherichia coli
Taurine enters into the cytoplasm through a taurine ATP-binding cassette (ABC) transporters. Once inside, the enzyme taurine dioxygenase encourages the interaction between taurine, oxoglutaric acid and oxygen resulting in the release of succinic acid, sulfite, aminoacetaldehyde, and carbon dioxide.

PW001028

Pw001028 View Pathway
metabolic

Taurine Metabolism I

Escherichia coli
Taurine is incorporated into the cytoplasm through a taurine ABC transporter. Once inside the cytoplasm, taurine interacts with an oxoglutaric acid and an oxygen through a taurine dioxygenase resulting in the release of succinic acid, sulfite , aminoacetaldehyde and carbon dioxide.

PW145556

Pw145556 View Pathway
drug action

Taurocholic acid Drug Metabolism Action Pathway

Homo sapiens

PW146531

Pw146531 View Pathway
drug action

Taurolidine Drug Metabolism Action Pathway

Homo sapiens

PW176142

Pw176142 View Pathway
metabolic

Taurolidine Predicted Metabolism Pathway new

Homo sapiens
Metabolites of Taurolidine are predicted with biotransformer.

PW145851

Pw145851 View Pathway
drug action

Tauroursodeoxycholic acid Drug Metabolism Action Pathway

Homo sapiens

PW127415

Pw127415 View Pathway
drug action

Tavaborole Action Pathway

Homo sapiens
Tavaborole is an antifungal agent used to treat onychomycosis, a fungal infection of the nail and nail bed due to Trichophyton rubrum or Trichophyton mentagrophytes infection. Tavaborole functions by inhibiting Leucyl-tRNA synthetase, or LeuRS, an essential fungal enzyme required for protein synthesis and for the catalysis of ATP-dependent ligation of L-leucine to tRNA(Leu). This blocks the protein synthesis in the fungal cell which leads to cell degradation and death.